Perceptive Advisors had a rough 2021.
The life sciences and biopharma specialist’s main hedge fund, Perceptive Life Sciences Fund, suffered its worst loss in its 23-year history, dropping nearly 28 percent for the year.
Meanwhile, the initial public offering of a company essentially created by Perceptive has so far been a disaster.
